Showing 1 - 20 results of 146 for search '(( significantly related decrease ) OR ( significantly ((_ decrease) OR (larger decrease)) ))~', query time: 0.52s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    “…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    “…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
  10. 10

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    “…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Study Data. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. …”
  19. 19

    Study outcomes. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. …”
  20. 20

    Patient characteristics. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. …”